VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,000 | -88.2% | 857 | -78.5% | 0.00% | – |
| Q4 2020 | $34,000 | +142.9% | 3,981 | +203.0% | 0.00% | – |
| Q3 2020 | $14,000 | -99.6% | 1,314 | -99.5% | 0.00% | -100.0% |
| Q2 2020 | $3,419,000 | +139.9% | 256,410 | +56.6% | 0.00% | +50.0% |
| Q1 2020 | $1,425,000 | -39.5% | 163,765 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $2,357,000 | +4108.9% | 168,928 | +5117.0% | 0.00% | – |
| Q3 2019 | $56,000 | -26.3% | 3,238 | +15.2% | 0.00% | – |
| Q2 2019 | $76,000 | +406.7% | 2,811 | +244.1% | 0.00% | – |
| Q1 2019 | $15,000 | +275.0% | 817 | +95.0% | 0.00% | – |
| Q4 2018 | $4,000 | -83.3% | 419 | -66.9% | 0.00% | – |
| Q3 2018 | $24,000 | -4.0% | 1,265 | -0.3% | 0.00% | – |
| Q2 2018 | $25,000 | -21.9% | 1,269 | -26.1% | 0.00% | – |
| Q1 2018 | $32,000 | +113.3% | 1,717 | +87.2% | 0.00% | – |
| Q4 2017 | $15,000 | +650.0% | 917 | +683.8% | 0.00% | – |
| Q3 2017 | $2,000 | -99.4% | 117 | -99.6% | 0.00% | – |
| Q4 2016 | $340,000 | +325.0% | 27,293 | +306.3% | 0.00% | – |
| Q3 2016 | $80,000 | +42.9% | 6,718 | +32.8% | 0.00% | – |
| Q2 2016 | $56,000 | – | 5,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |